Patents Assigned to Sapphire Therapeutics, Inc.
  • Methods of treating emesis using growth hormone secretagogues
    Publication number: 20080300194
    Abstract: The present invention relates to methods of treating or preventing emesis and improving a subject's ASAS score by administering to the subject an effective amount of a growth hormone secretagogue compound or a pharmaceutically acceptable salt, hydrate or solvate thereof.
    Type: Application
    Filed: April 10, 2008
    Publication date: December 4, 2008
    Applicant: Sapphire Therapeutics, Inc.
    Inventors: William R. Mann, William J. Polvino